Celldex Therapeutics Inc
NASDAQ:CLDX
Cash Flow Statement
Cash Flow Statement
Celldex Therapeutics Inc
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Net Income |
(94)
|
(103)
|
(108)
|
(118)
|
(118)
|
(122)
|
(126)
|
(127)
|
(132)
|
(131)
|
(129)
|
(129)
|
(128)
|
(125)
|
(122)
|
(93)
|
(177)
|
(165)
|
(146)
|
(151)
|
(50)
|
(46)
|
(50)
|
(51)
|
(46)
|
(46)
|
(48)
|
(60)
|
(64)
|
(66)
|
(72)
|
(71)
|
(77)
|
(100)
|
(106)
|
(112)
|
(119)
|
(113)
|
(125)
|
(141)
|
(145)
|
|
Depreciation & Amortization |
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
Stock-Based Compensation |
5
|
6
|
6
|
7
|
8
|
9
|
11
|
13
|
14
|
16
|
16
|
15
|
15
|
14
|
13
|
12
|
11
|
10
|
9
|
8
|
7
|
7
|
6
|
5
|
4
|
3
|
3
|
4
|
5
|
5
|
7
|
9
|
11
|
13
|
14
|
16
|
17
|
19
|
21
|
24
|
27
|
|
Other Non-Cash Items |
3
|
5
|
5
|
7
|
9
|
9
|
11
|
13
|
18
|
20
|
19
|
18
|
19
|
19
|
21
|
(0)
|
91
|
82
|
71
|
88
|
(5)
|
(1)
|
3
|
4
|
0
|
(1)
|
2
|
16
|
17
|
20
|
19
|
8
|
9
|
5
|
9
|
10
|
9
|
16
|
17
|
18
|
18
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
6
|
10
|
6
|
6
|
4
|
3
|
4
|
11
|
8
|
(3)
|
(1)
|
(7)
|
(9)
|
0
|
(5)
|
(12)
|
(11)
|
(11)
|
(9)
|
(15)
|
(9)
|
(12)
|
(8)
|
(4)
|
(4)
|
(3)
|
(4)
|
(0)
|
(3)
|
(4)
|
(1)
|
(1)
|
(3)
|
14
|
(2)
|
(4)
|
(1)
|
(18)
|
9
|
13
|
4
|
|
Cash from Operating Activities |
(82)
N/A
|
(85)
-3%
|
(94)
-11%
|
(102)
-8%
|
(102)
-1%
|
(106)
-4%
|
(107)
-1%
|
(99)
+8%
|
(101)
-2%
|
(110)
-9%
|
(106)
+3%
|
(113)
-6%
|
(113)
0%
|
(100)
+11%
|
(101)
0%
|
(100)
+1%
|
(93)
+7%
|
(89)
+4%
|
(79)
+11%
|
(75)
+5%
|
(60)
+20%
|
(54)
+11%
|
(51)
+6%
|
(46)
+9%
|
(45)
+2%
|
(45)
0%
|
(46)
-2%
|
(40)
+13%
|
(46)
-15%
|
(47)
-2%
|
(52)
-10%
|
(61)
-18%
|
(67)
-11%
|
(78)
-15%
|
(96)
-24%
|
(104)
-8%
|
(108)
-4%
|
(113)
-5%
|
(97)
+14%
|
(107)
-11%
|
(119)
-11%
|
|
Investing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Capital Expenditures |
(4)
|
(4)
|
(4)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
|
Other Items |
(108)
|
(81)
|
(68)
|
(39)
|
(21)
|
(42)
|
(47)
|
(45)
|
44
|
60
|
62
|
72
|
68
|
104
|
90
|
48
|
41
|
18
|
14
|
31
|
31
|
10
|
18
|
18
|
24
|
(76)
|
(124)
|
(97)
|
(75)
|
19
|
(165)
|
(215)
|
(248)
|
(208)
|
42
|
92
|
134
|
110
|
98
|
(104)
|
(472)
|
|
Cash from Investing Activities |
(112)
N/A
|
(85)
+24%
|
(73)
+15%
|
(41)
+43%
|
(25)
+40%
|
(45)
-84%
|
(51)
-13%
|
(50)
+2%
|
40
N/A
|
57
+42%
|
60
+5%
|
69
+15%
|
66
-5%
|
101
+53%
|
88
-13%
|
46
-47%
|
40
-15%
|
17
-57%
|
13
-23%
|
30
+128%
|
31
+3%
|
9
-69%
|
17
+82%
|
17
-1%
|
23
+33%
|
(78)
N/A
|
(126)
-62%
|
(98)
+22%
|
(77)
+22%
|
18
N/A
|
(166)
N/A
|
(216)
-30%
|
(249)
-15%
|
(210)
+16%
|
40
N/A
|
90
+126%
|
132
+47%
|
108
-18%
|
97
-11%
|
(106)
N/A
|
(474)
-348%
|
|
Financing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Net Issuance of Common Stock |
180
|
180
|
180
|
0
|
189
|
191
|
192
|
193
|
4
|
4
|
11
|
14
|
27
|
33
|
36
|
51
|
50
|
50
|
44
|
29
|
21
|
20
|
17
|
16
|
14
|
172
|
173
|
171
|
0
|
4
|
270
|
270
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
216
|
649
|
|
Net Issuance of Debt |
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
6
|
5
|
0
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
5
|
2
|
2
|
5
|
|
Cash from Financing Activities |
176
N/A
|
185
+5%
|
185
0%
|
1
-99%
|
192
+16 330%
|
192
+0%
|
193
+0%
|
193
+0%
|
2
-99%
|
4
+137%
|
12
+192%
|
14
+26%
|
27
+87%
|
33
+22%
|
36
+9%
|
51
+42%
|
50
-2%
|
50
-1%
|
44
-11%
|
29
-34%
|
22
-27%
|
20
-5%
|
17
-15%
|
16
-7%
|
14
-15%
|
172
+1 149%
|
174
+1%
|
171
-1%
|
170
-1%
|
5
-97%
|
272
+5 826%
|
272
+0%
|
273
+0%
|
273
+0%
|
3
-99%
|
4
+32%
|
4
+10%
|
5
+1%
|
2
-45%
|
218
+8 709%
|
654
+199%
|
|
Change in Cash | ||||||||||||||||||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Change in Cash |
(19)
N/A
|
15
N/A
|
18
+20%
|
(141)
N/A
|
65
N/A
|
41
-38%
|
34
-16%
|
44
+29%
|
(59)
N/A
|
(49)
+17%
|
(35)
+29%
|
(30)
+15%
|
(21)
+31%
|
34
N/A
|
23
-32%
|
(2)
N/A
|
(3)
-23%
|
(22)
-734%
|
(22)
+2%
|
(16)
+27%
|
(8)
+48%
|
(24)
-191%
|
(16)
+33%
|
(13)
+19%
|
(9)
+33%
|
48
N/A
|
2
-97%
|
33
+1 990%
|
47
+43%
|
(25)
N/A
|
54
N/A
|
(5)
N/A
|
(44)
-837%
|
(15)
+66%
|
(54)
-256%
|
(10)
+82%
|
29
N/A
|
(0)
N/A
|
3
N/A
|
5
+111%
|
61
+1 032%
|
|
Free Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Free Cash Flow |
(87)
N/A
|
(90)
-3%
|
(98)
-10%
|
(103)
-5%
|
(106)
-2%
|
(110)
-4%
|
(112)
-2%
|
(104)
+7%
|
(105)
-1%
|
(113)
-8%
|
(109)
+4%
|
(116)
-6%
|
(116)
0%
|
(103)
+11%
|
(103)
+0%
|
(102)
+1%
|
(94)
+7%
|
(90)
+4%
|
(80)
+11%
|
(76)
+5%
|
(61)
+20%
|
(55)
+10%
|
(52)
+6%
|
(47)
+9%
|
(46)
+2%
|
(47)
-2%
|
(48)
-2%
|
(42)
+12%
|
(48)
-15%
|
(48)
+0%
|
(53)
-9%
|
(62)
-18%
|
(69)
-10%
|
(79)
-16%
|
(98)
-24%
|
(106)
-7%
|
(110)
-4%
|
(114)
-4%
|
(98)
+14%
|
(109)
-11%
|
(121)
-11%
|